Dianthus Therapeutics

About:

Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.

Website: https://dianthustx.com

Top Investors: RA Capital Management, Fidelity, RTW Investments, Wedbush Securities, Catalio Capital Management

Description:

Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach. DNTH103 is a new medicine in development for serious autoimmune diseases. It targets a specific part of the immune system and could be a self-administered injection for some patients.